Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
about
Direct detection of alternative open reading frames translation products in human significantly expands the proteomeGuidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchIdentification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screeningCurrent status of biomarker research in neurologyRevolutionizing Alzheimer's disease and clinical trials through biomarkersClinical proteomics of enervated neuronsFacilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich ImmunoassaysFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsPro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's DiseaseClearance systems in the brain-implications for Alzheimer diseasePreanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationAutosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADBiological markers of Alzheimer's diseaseRole of HIV in amyloid metabolismCarnosinases, their substrates and diseasesBody fluid biomarkers in Alzheimer's diseaseMeta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic CriteriaPlatelets and Alzheimer's disease: Potential of APP as a biomarkerThe role of tau in neurodegenerative diseases and its potential as a therapeutic targetA window into the heterogeneity of human cerebrospinal fluid Aβ peptidesBiomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomicsMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseasePassive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy modelsHSV-1 and Alzheimer's disease: more than a hypothesis.Exploring Biomarkers for Alzheimer's DiseaseCerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's diseaseBACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous systemMetabolite profiling of Alzheimer's disease cerebrospinal fluidHigh Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal FluidPreferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shiftCerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Teamγ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF AβComparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up studyMultivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome datasetAssociation between IgM anti-herpes simplex virus and plasma amyloid-beta levelsAβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's diseaseGenome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohortA Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's diseaseExploiting thermodynamic data to optimize the enantioseparation of underivatized amino acids in ligand exchange capillary electrophoresis.
P2860
Q21132658-FEAAD262-BD8A-49A3-9E81-F9CF9961106FQ24289435-AF44C7B3-764E-4F8D-96DB-E466BF8DF981Q24630334-9B5FD904-B609-433B-A622-FF9DB5431854Q26744505-E7C5E6FB-E86C-4C83-8F71-9FC70379ADE4Q26744882-6B20BAE2-1E38-4737-A607-DA4F8E019862Q26752052-F92F31E9-D319-47FB-AC0F-8F382421CF69Q26781562-3AC52B71-EEEA-4510-A63D-08BC27BD566FQ26784569-CCA48733-3FB8-4DBE-BC79-B6A89F52E2D4Q26795492-8F357CF2-BE63-4B23-B1A3-757DAB08CCCBQ26801541-24568DE3-1E32-4ED3-BD20-E932A1F4851CQ26801663-84C7D364-12D5-488F-A7D4-E8E8F3678915Q26801666-CA0B4D9B-B045-4D4D-A78F-1927D916387CQ26823847-A674A022-A0B1-49D0-B212-52E67920230DQ26824179-F7FE6BC6-7605-404C-8CFE-EBB96FB9E57AQ26829095-4FDD28EF-ACBB-46DC-A53B-43E68F80DCC1Q26830098-78C42B5E-4625-47B4-AC7D-09830871531AQ26864063-382270DE-66F6-4843-84C9-3F3CE922B276Q27001550-86E5A33E-3696-47DB-8818-930237045DBFQ27005032-CE50471A-1B7C-4071-9DCE-A5503F73AB1DQ27010785-EDE3C4E1-DFB0-4699-8B11-7220AE05C660Q27024518-8D03F213-4A02-4F5C-83C2-F1E05BA476F4Q27027319-E298F222-1DD6-42E4-9E1D-4AF27DE23D09Q27308146-765CCA52-7A3D-48F6-BACB-FB66440BD813Q27692651-EB4FCB2B-D5F4-4390-A4C6-91C631E7F950Q28079218-B29D5104-76F3-46C8-B639-D14DCEBADB82Q28087176-054DA017-C268-49BA-8DE8-FD0B02C5542AQ28480522-06FCE966-086D-471C-A0C4-8E5C1D849A97Q28480903-FB767E6A-6453-4C2D-8109-368A2D09B831Q28547231-21C40FF7-CEA4-4520-A5A3-229BED067E08Q28582464-411DBE31-B32F-43DB-B930-4759E962E84FQ28595520-7E3AB6A6-BACF-4D7C-BD25-D80C456A7C07Q28687678-50793081-DFFF-4E97-BF97-441151A11B2AQ28728080-EB9268FC-92FB-4583-A5ED-78E95834A93CQ28730795-5606DF45-A832-4024-ABD3-DC93649DADB5Q28740764-BE03874D-7FA1-4D9C-96F6-B0CD329314E9Q28743838-9D2854A6-7A3E-4C03-8694-F11974942159Q29417147-C7109D25-B1B0-4E70-84E4-477E6E61D856Q30235315-5C8CAF8C-B9E1-45A7-AC11-D63B2F4F4514Q30497749-0FBE78C0-452A-4DD3-9DE8-0B6681807C80Q30563736-B31252CD-394A-46C1-BDAF-57B29A2AA735
P2860
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@ast
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@en
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@nl
type
label
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@ast
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@en
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@nl
prefLabel
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@ast
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@en
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@nl
P2860
P50
P921
P356
P1476
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
@en
P2093
Michael Weiner
P2860
P2888
P304
P356
10.1038/NRNEUROL.2010.4
P407
P577
2010-02-16T00:00:00Z
P5875
P6179
1016181353